文献速递肺外科心外重症与机械循环支持

以静脉-静脉体外膜氧合桥接的肺移植患者术中体外支持策略

Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation.
PubMed 文献 · J Heart Lung Transplant · 2018-09-05

该回顾性队列研究纳入2007至2016年34例仅以VV ECMO桥接成功过渡至肺移植的患者,术中58.8%继续VV ECMO、32.3%转为中央VA ECMO、8.8%需体外循环。两种术中ECMO类型的术后ECMO时长、因出血开胸、肾脏替代治疗及90天死亡率与长期生存均无显著差异。结论认为术中沿用现有VV ECMO桥接是可行的。

要点

  • 桥接中位时长12天(IQR 7–19天),术中58.8%继续VV ECMO、32.3%转为中央VA ECMO。
  • VV与VA组90天死亡率分别为0%与9.0%(p=0.35),长期生存无显著差异(p=0.59)。
  • VA组术中红细胞输注有偏高趋势(5[4–9] vs 8[6–13]单位,p=0.06)。

核心结论

  • 肺移植术中沿用现有VV ECMO桥接是可行的,其结局与因血流动力学受损转为中央VA ECMO的患者相当。

研究设计与样本

  • 单中心回顾性队列研究,纳入2007至2016年34例仅以VV ECMO成功桥接至肺移植的患者。

主要发现

  • 桥接中位时长12天(IQR 7至19天),术中3例(8.8%)需体外循环、20例(58.8%)继续VV ECMO、11例(32.3%)转为中央VA ECMO。
  • VV与VA两种术中ECMO在术后ECMO时长、因出血开胸或肾脏替代治疗方面无显著差异。
  • 90天死亡率分别为0%与9.0%(p=0.35),长期生存无显著差异(p=0.59)。
  • VA组术中红细胞输注有偏高趋势(5[4至9] vs 8[6至13]单位,p=0.06)。
  • 术中改用VA ECMO与使用低流量VV装置桥接及肺叶移植相关。

关键数值与推荐

  • 转为术中VA ECMO的指征为血流动力学受损(全身低血压或平均肺动脉压>40 mm Hg)或高度预期出现该情况。

临床怎么用

  • 对VV ECMO桥接的肺移植患者,术中可继续沿用VV ECMO,无需常规升级为中央VA ECMO。
  • 仅在出现全身低血压或平均肺动脉压>40 mm Hg等血流动力学受损时考虑转为VA ECMO。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is the preferred configuration for bridging respiratory failure patients while awaiting lung transplantation. However, there is no consensus on intraoperative extracorporeal cardiopulmonary support during lung transplantation in these patients. METHODS: The configuration of the intraoperative extracorporeal circuit after VV ECMO bridge was reviewed and correlated with clinical outcomes. This retrospective cohort study performed at our university hospital included 34 patients who were successfully bridged solely with VV ECMO to lung transplantation during the period 2007 to 2016. Indications to switch to intraoperative venoarterial (VA) ECMO were hemodynamic compromise (systemic hypotension or mean pulmonary artery pressure >40 mm Hg) or when this scenario was thought to be highly likely. RESULTS: The median duration of bridging was 12 (IQR 7 to 19) days. Intraoperatively, 3 patients (8.8%) required cardiopulmonary bypass. Twenty patients (58.8%) stayed on VV ECMO and 11 (32.3%) were switched to central VA ECMO. Between the 2 types of intraoperative ECMO (VV vs VA), there were no significant differences in post-operative ECMO duration, chest reopening for bleeding, or renal replacement therapy. There was no significant difference in 90-day mortality (0% and 9.0%, p = 0.35) or in long-term survival (p = 0.59). The intraoperative transfusion of red blood cells tended to be higher in the VA group (5 [4 to 9] vs 8 [6 to 13] units, p = 0.06). Use of intraoperative VA ECMO was associated with the use of low-flow VV device bridging and lobar transplantation. CONCLUSIONS: Using the existing VV ECMO bridge intraoperatively during lung transplantation is feasible and provides comparable outcomes to patients converted to central VA ECMO for compromised hemodynamics.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Hashimoto K, Hoetzenecker K, Yeung JC, et al. Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation. J Heart Lung Transplant. 2018. PMID: 30193763. doi:10.1016/j.healun.2018.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。